Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Oncology Report

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR_00000924PMID 20664990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the recognition and functional heterogeneity exhibited by cytokine‐induced killer cell subsets against acute myeloid leukaemia target cell

  2009cited by this paper
• Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine1

  2009cited by this paper
• BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.

  2009cited by this paper
• Prognostic importance of T and NK‐cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia

  2008cited by this paper
• Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

  2008cited by this paper
• CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.

  2008cited by this paper
• Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.

  2008cited by this paper
• Phenotypic and Functional Changes of Cytotoxic CD56pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus Infection

  2007cited by this paper
• T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil

  2006cited by this paper
• CD4+CD25+ Tregs and NKT cells: regulators regulating regulators.

  2006cited by this paper
• Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

  2006cited by this paper
• The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.

  2006cited by this paper
• Comparison of methods for determining zeta‐chain associated protein – 70 (ZAP‐70) expression in patients with B‐cell chronic lymphocytic leukemia (B‐CLL)

  2006cited by this paper
• Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).

  2006cited by this paper
• Characterization of NKR+ T-cell subsets in human bone marrow: implications for immunosurveillance of neoplasia.

  2005cited by this paper
• High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia

  2005cited by this paper
• The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.

  2005cited by this paper
• The LPL / ADAM 29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia

  2005cited by this paper
• The peripheral blood Valpha24+ NKT cell numbers decrease in patients with haematopoietic malignancy.

  2005cited by this paper
• Role of NK and NKT cells in the immunopathogenesis of HCV‐induced hepatitis

  2004cited by this paper
• The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection.

  2004cited by this paper
• CD1d is expressed on B‐chronic lymphocytic leukemia cells and mediates α‐galactosylceramide presentation to natural killer T lymphocytes

  2004cited by this paper
• Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy

  2003cited by this paper
• ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia

  2003cited by this paper
• ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

  2003cited by this paper
• Cytokine-induced Killer Cells: NK-like T Cells with Cytotolytic Specificity against Leukemia

  2003cited by this paper
• Abnormal T-cell Function in B-cell Chronic Lymphocytic Leukaemia

  2003cited by this paper
• Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.

  2002cited by this paper
• Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients.

  2002cited by this paper
• Natural killer T (NKT) cells and their role in antitumor immunity.

  2002cited by this paper
• Chronic B cell malignancies and bone marrow microenvironment.

  2002cited by this paper
• Molecular biology of NK T cell specificity and development.

  2000cited by this paper
• A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon α and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cells

  2000cited by this paper
• The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.

  1999cited by this paper
• Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells.

  1999cited by this paper
• Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

  1999cited by this paper
• Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

  1999cited by this paper
• Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes

  1997cited by this paper
• Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2.

  1996cited by this paper
• National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

  1996cited by this paper
• Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.

  1995cited by this paper
• Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.

  1991cited by this paper
• IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.

  1990cited by this paper
• Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity.

  1990cited by this paper
• Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.

  1987cited by this paper
• The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

  1986cited by this paper
• A subset of natural killer cells in peripheral blood displays a mature T cell phenotype

  1986cited by this paper
• Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data.

  1984cited by this paper
• Clinical staging of chronic lymphocytic leukemia.

  1977cited by this paper
• Clinical staging of chronic lymphocytic leukemia.

  1975cited by this paper

• Prognostic relevance of bone marrow immune cell fractions in newly diagnosed B-cell non-Hodgkin lymphoma patients

  2025cites this paper
• Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin D

  2025cites this paper
• Age‐Matched Reference Values for Circulating Natural Killer T (NKT)‐Like Cells

  2025cites this paper
• Polyfunctional CD8+ CD226+ RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia

  2025cites this paper
• Overview on Immunopathology of Chronic Lymphocytic Leukemia and Tumor-Associated Antigens with Therapeutic Applications

  2024cites this paper
• Phenotypic and functional exhaustion of circulating CD3+CD56+ NKT‐like cells in colorectal cancer patients

  2024cites this paper
• CD3+CD56+ and CD3-CD56+ lymphocytes in the cerebrospinal fluid of persons with HIV-1 subtypes B and C.

  2023cites this paper
• Natural Killer T-like Cells: Immunobiology and Role in Disease

  2023cites this paper
• Preliminary analysis of double‐negative T, double‐positive T, and natural killer T‐like cells in B‐cell chronic lymphocytic leukemia

  2023cites this paper
• Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA)

  2023influential citation
• Acute exercise mobilizes NKT-like cells with a cytotoxic transcriptomic profile but does not augment the potency of cytokine-induced killer (CIK) cells

  2022cites this paper
• Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD3+CD56+ NKT-Like Cells

  2022cites this paper
• A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia

  2022cites this paper
• Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia

  2022cites this paper
• Human CD3+CD56+NKT-like cells express a range of complement receptors and C3 activation has negative effects on these cell activity and effector function.

  2021cites this paper
• Can we define CD3+CD56+ cells as NKT cells with impunity?

  2021cites this paper
• PD-1 blockade improves the anti-tumor potency of exhausted CD3+CD56+ NKT-like cells in patients with primary hepatocellular carcinoma

  2021cites this paper
• [Effects of neoadjuvant chemoradiotherapy on infiltrating immune cells in the tumor microenvironment of rectal cancer].

  2021cites this paper
• Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia

  2021cites this paper
• High Levels of CD38+ NK Cells Contribute to Immune Imbalance of Th1/Th2 and Th17/Treg in Rheumatoid Arthritis

  2020cites this paper
• CD markers variations in chronic lymphocytic leukemia: New insights into prognosis

  2019influential citation
• Diminished Frequency of Menstrual and Peripheral Blood NKT-Like Cells in Patients With Unexplained Recurrent Spontaneous Abortion and Infertile Women

  2019influential citation
• NKT-Like (CD3+CD56+) Cells in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors

  2019cites this paper
• The Eμ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia

  2018cites this paper
• Decline in peripheral blood NKG2D+CD3+CD56+ NKT cells in metastatic colorectal cancer patients.

  2018cites this paper
• Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin's lymphoma.

  2017cites this paper
• Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia

  2017cites this paper
• Comparison of 6B11 mAb and α-GalCer-loaded CD1d dextramers for detection of iNKT cells by flow cytometry.

  2017cites this paper
• Caractérisation des lymphocytes B régulateurs dans la leucémie lymphoïde chronique

  2016cites this paper
• Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer

  2016cites this paper
• CD4+CD56+ NKT-like cells secreting interferon-γ are associated with incident coronary events

  2016cites this paper
• CD4+CD56+ natural killer T‐like cells secreting interferon‐γ are associated with incident coronary events

  2016cites this paper
• Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus

  2016cites this paper
• CC-122 immunomodulatory effects in refractory patients with diffuse large B-cell lymphoma

  2016cites this paper
• Interleukin-15 enhances the expansion and function of natural killer T cells from adult peripheral and umbilical cord blood.

  2015cites this paper
• The Function of CD 3 + CD 56 + NKT-Like Cells in HIV-Infected Individuals

  2015cites this paper
• Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5+ B cell expansion

  2015cites this paper
• The Function of CD3+CD56+ NKT-Like Cells in HIV-Infected Individuals

  2014cites this paper
• Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B.

  2014cites this paper
• Functional analysis of MICA polymorphism : with an emphasis on Behcet's disease

  2013cites this paper
• High circulating CD3+CD56+CD16+ natural killer-like T cell levels predict a better IVF treatment outcome.

  2013cites this paper
• Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications.

  2013cites this paper
• The role of natural killer T cells in B cell malignancies

  2013cites this paper
• Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy.

  2012cites this paper
• Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia

  2012influential citation
• Surface profiles for subclassification of chronic lymphocytic leukemia

  2012cites this paper
• Increased numbers but functional defects of CD56+CD3+ cells in lung cancer.

  2012cites this paper
• Increased numbers but functional defects of CD 56 1 CD 3 1 cells in lung cancer

  2012cites this paper
• Surface profi les for subclassifi cation of chronic lymphocytic leukemia

  2012cites this paper
• A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?

  2011cites this paper